SKI Market

Indian Indices

Sensex

82,225.92 -1,068.74
( -1.28%)

Global Indices

Nasdaq

48,816.07 -830.91
(-1.67%)

Dow Jones

6,858.07 -72.44
(-1.05%)

Hang Seng

57,337.44 511.74
(0.90%)

Nikkei 225

10,664.46 -22.43
(-0.21%)

Forex

USD-INR

90.72 -0.31
(-0.34%)

EUR-INR

106.89 -0.33
(-0.31%)

GBP-INR

122.26 -0.41
(-0.34%)

JPY-INR

0.59 0.00
(-0.41%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Medicamen Biotech Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

531146

INE646B01010

200.5802003

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MEDICAMEQ

46.44

410

EPS(TTM)

Face Value()

Div & Yield %

6.51

0.31

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	151.46	172.39	137.88	115.45	110.15	117.34
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	151.46	172.39	137.88	115.45	110.15	117.34
Other Income	6.23	2.30	2.46	1.72	0.75	1.91
Stock Adjustments	6.08	13.32	10.30	3.34	-1.04	1.53
Total Income	163.77	188.01	150.64	120.51	109.86	120.78
EXPENDITURE :
Raw Materials	88.83	104.70	81.80	55.69	65.84	74.49
Power & Fuel Cost	6.94	7.12	5.67	5.86	2.68	2.90
Employee Cost	21.57	22.12	18.57	14.50	8.79	9.29
Other Manufacturing Expenses	10.87	10.24	8.70	9.60	7.37	9.10
Selling & Administrative Expenses	10.59	12.42	6.65	7.50	3.94	4.43
Miscellaneous Expenses	1.64	1.87	2.18	1.52	0.46	0.54
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	140.43	158.47	123.56	94.69	89.08	100.75
Operating Profit	23.34	29.55	27.08	25.82	20.78	20.03
Interest	3.60	5.65	3.39	1.94	1.51	0.93
Gross Profit	19.74	23.90	23.69	23.88	19.27	19.10
Depreciation	6.96	7.01	6.35	5.77	2.52	2.50
Profit Before Tax	12.78	16.89	17.34	18.11	16.75	16.60
Tax	3.64	4.22	3.70	3.98	4.15	4.60
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	-0.31	-0.63	-1.37	-0.78	0.12	-0.25
Reported Net Profit	9.45	13.30	15.00	14.91	12.49	12.26
Extraordinary Items	0.00	0.00	-0.01	0.00	0.00	-0.04
Adjusted Net Profit	9.45	13.30	15.01	14.91	12.49	12.30
Adjustment below Net Profit	0.26	0.00	0.09	0.00	0.00	0.00
P & L Balance brought forward	94.18	82.15	68.32	54.43	42.56	31.77
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	1.27	1.27	1.27	1.22	0.61	1.47
P & L Balance carried down	102.61	94.18	82.15	68.12	54.43	42.56
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	10.00	10.00	10.00	10.00	10.00	5.00
Dividend Per Share(Rs)	1.00	1.00	1.00	1.00	1.00	0.50
Earnings Per Share-Unit Curr	7.43	10.46	11.86	12.20	10.22	10.03
Earnings Per Share(Adj)-Unit Curr	7.43	10.46	11.86	12.20	10.22	10.03
Book Value-Unit Curr	171.17	164.54	152.30	121.18	109.98	100.25
Book Value(Adj)-Unit Curr	171.17	164.54	152.30	121.18	109.98	100.25

82,225.92 -1,068.74 ( -1.28%)

48,816.07 -830.91 (-1.67%)

6,858.07 -72.44 (-1.05%)

57,337.44 511.74 (0.90%)

10,664.46 -22.43 (-0.21%)

90.72 -0.31 (-0.34%)

106.89 -0.33 (-0.31%)

122.26 -0.41 (-0.34%)

0.59 0.00 (-0.41%)